Drugs / PEAPROSTIL
last change Apr 2025 re-read 2 minutes ago

PEAPROSTIL

Developed for
benign prostatic hyperplasia

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT06181175 Comparator Oct 2021 → Oct 2024 benign prostatic hyperplasia, urinary tract obstruction Azienda Ospedaliero Universitaria Maggiore della Carita Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PEAPROSTIL ClinicalTrials.gov intervention name — accepted as the source's own label NCT06181175
Route Oral “PEAPROSTIL 600 mg one sachet oral daily” NCT06181175